Blauvelt A, Leonardi C, Zachariae C, Burge R, Ridenour T, McKean-Matthews M, Garces S, Cameron G. Efficacy, Health-Related Outcomes, and Safety of Ixekizumamb for up to Five Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis. J of Skin [Internet]. 2017Oct.27 [cited 2024Jul.22];1(3.1):s12. Available from: https://jofskin.org/index.php/skin/article/view/174